Goldman Sachs Group Inc Ocular Therapeutix, Inc Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 576,238 shares of OCUL stock, worth $4.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
576,238
Previous 679,417 15.19%
Holding current value
$4.7 Million
Previous $4.65 Million 7.88%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$6.45 - $9.23 $665,504 - $952,342
-103,179 Reduced 15.19%
576,238 $5.01 Million
Q2 2024

Aug 13, 2024
BUY
$4.2 - $8.69 $1.72 Million - $3.56 Million
410,236 Added 152.4%
679,417 $4.65 Million
Q1 2024

May 15, 2024
BUY
$3.85 - $10.93 $699,267 - $1.99 Million
181,628 Added 207.45%
269,181 $2.45 Million
Q4 2023

Feb 13, 2024
SELL
$2.08 - $4.52 $57,892 - $125,805
-27,833 Reduced 24.12%
87,553 $390,000
Q3 2023

May 14, 2024
BUY
$3.14 - $5.04 $87,395 - $140,278
27,833 Added 31.79%
115,386 $362,000
Q3 2023

Nov 14, 2023
SELL
$3.14 - $5.04 $289,212 - $464,214
-92,106 Reduced 44.39%
115,386 $362,000
Q2 2023

May 14, 2024
BUY
$4.6 - $7.64 $123,404 - $204,958
26,827 Added 14.85%
207,492 $1.07 Million
Q2 2023

Aug 14, 2023
BUY
$4.6 - $7.64 $123,404 - $204,958
26,827 Added 14.85%
207,492 $1.07 Million
Q1 2023

May 14, 2024
SELL
$2.79 - $6.27 $4,380 - $9,843
-1,570 Reduced 0.86%
180,665 $952,000
Q1 2023

May 11, 2023
SELL
$2.79 - $6.27 $4,380 - $9,843
-1,570 Reduced 0.86%
180,665 $952,000
Q4 2022

May 14, 2024
SELL
$2.61 - $4.41 $392,836 - $663,757
-150,512 Reduced 45.23%
182,235 $512,000
Q4 2022

Feb 13, 2023
SELL
$2.61 - $4.41 $392,836 - $663,757
-150,512 Reduced 45.23%
182,235 $512,000
Q3 2022

May 14, 2024
SELL
$4.09 - $6.5 $554,199 - $880,756
-135,501 Reduced 28.94%
332,747 $1.38 Million
Q3 2022

Nov 10, 2022
SELL
$4.09 - $6.5 $554,199 - $880,756
-135,501 Reduced 28.94%
332,747 $1.38 Million
Q2 2022

May 14, 2024
BUY
$3.01 - $5.22 $1.15 Million - $1.99 Million
380,695 Added 434.82%
468,248 $1.88 Million
Q2 2022

Aug 15, 2022
BUY
$3.01 - $5.22 $252,412 - $437,738
83,858 Added 21.82%
468,248 $1.88 Million
Q1 2022

May 16, 2022
BUY
$4.83 - $7.35 $809,319 - $1.23 Million
167,561 Added 77.28%
384,390 $1.9 Million
Q4 2021

Feb 14, 2022
SELL
$6.16 - $12.07 $627,931 - $1.23 Million
-101,937 Reduced 31.98%
216,829 $1.51 Million
Q3 2021

Nov 10, 2021
BUY
$9.7 - $14.34 $3.09 Million - $4.57 Million
318,766 New
318,766 $3.19 Million

Others Institutions Holding OCUL

# of Institutions
180
Shares Held
136M
Call Options Held
150K
Put Options Held
225K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $627M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email